GlaxoSmithKline plc (GLAXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 71.40B |
| Enterprise value | 89.96B |
| Trailing P/E | 12.75 |
| Forward P/E | 9.30 |
| PEG ratio (5-yr expected) | 1.07 |
| Price/sales (ttm) | 1.48 |
| Price/book (mrq) | 6.24 |
| Enterprise value/revenue | 2.34 |
| Enterprise value/EBITDA | 9.18 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.29 |
| 52-week change 3 | -18.82% |
| S&P500 52-week change 3 | -9.85% |
| 52-week high 3 | 23.40 |
| 52-week low 3 | 13.48 |
| 50-day moving average 3 | 17.32 |
| 200-day moving average 3 | 18.38 |
Share statistics
| Avg vol (3-month) 3 | 3.52k |
| Avg vol (10-day) 3 | 3.08k |
| Shares outstanding 5 | 4.09B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 3.9B |
| % held by insiders 1 | 0.69% |
| % held by institutions 1 | 41.17% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.94 |
| Forward annual dividend yield 4 | 5.29% |
| Trailing annual dividend rate 3 | 0.76 |
| Trailing annual dividend yield 3 | 4.29% |
| 5-year average dividend yield 4 | 5.37 |
| Payout ratio 4 | 78.88% |
| Dividend date 3 | 12 Apr 2017 |
| Ex-dividend date 4 | 16 Nov 2022 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 35.65% |
| Operating margin (ttm) | 24.19% |
Management effectiveness
| Return on assets (ttm) | 8.36% |
| Return on equity (ttm) | 34.77% |
Income statement
| Revenue (ttm) | 38.44B |
| Revenue per share (ttm) | 9.56 |
| Quarterly revenue growth (yoy) | 18.10% |
| Gross profit (ttm) | 22.66B |
| EBITDA | 11.72B |
| Net income avi to common (ttm) | 4.46B |
| Diluted EPS (ttm) | 1.36 |
| Quarterly earnings growth (yoy) | 783.10% |
Balance sheet
| Total cash (mrq) | 7.16B |
| Total cash per share (mrq) | 1.77 |
| Total debt (mrq) | 22.12B |
| Total debt/equity (mrq) | 253.74 |
| Current ratio (mrq) | 0.97 |
| Book value per share (mrq) | 2.27 |
Cash flow statement
| Operating cash flow (ttm) | 9.27B |
| Levered free cash flow (ttm) | 9.04B |
© 2023 Yahoo. All rights reserved.
